EQL Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NGM:EQL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Dec 23	Sellkr9,900,002	FÅRö Capital Ab	Company		300,000	kr33.00

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 74.02% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30%	Cadila Pharmaceuticals Limited	8,718,500	kr377.5m	0%	no data
28%	FÅRö Capital Ab	8,127,348	kr351.9m	0%	97.07%
3.29%	Avanza Fonder AB	956,193	kr41.4m	0%	0.1%
2.19%	SEB Investment Management AB	636,493	kr27.6m	0%	0.01%
1.54%	Sten Irwe	447,580	kr19.4m	0%	no data
1.24%	Lars Fåhraeus	360,389	kr15.6m	0%	no data
1.19%	Carnegie Fonder AB	345,857	kr15.0m	0%	0.03%
1.1%	Emanuel Eriksson	319,700	kr13.8m	0%	no data
1.06%	Cliens Kapitalförvaltning AB	308,074	kr13.3m	0%	0.04%
1.03%	Martin Søkjer-Petersen	299,355	kr13.0m	0%	no data
0.88%	Axel Schorling	257,113	kr11.1m	0%	no data
0.88%	Alexander Brising	256,543	kr11.1m	0%	no data
0.86%	Schroder Investment Management Limited	250,000	kr10.8m	0%	no data
0.61%	Amundi Asset Management SAS	177,415	kr7.7m	246%	no data
0.052%	Martin Kristofferson	15,200	kr658.2k	0%	no data
0.047%	Anna Jonsson	13,729	kr594.5k	0%	no data
0.034%	Anders Mansson	10,000	kr433.0k	0%	no data
0.034%	Per Svangren	10,000	kr433.0k	0%	no data
0.0086%	Linda Neckmar	2,500	kr108.2k	0%	no data